![An illustration of kids in silhouette walking away with colorful backpacks](https://www.uc.edu/news/articles/2023/10/n21206763/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1698758104747.jpg)
U.S. News & World Report: Metformin may help young patients with bipolar disorder avoid weight gain
U.S. News & World Report highlighted recent research led by the University of Cincinnati and Northwell Health that found the drug metformin can help prevent or reduce weight gain in youth taking medication to treat bipolar disorder.
Medications to treat bipolar disorder, known as second-generation antipsychotics (SGAs), are often effective at helping young patients’ mental health improve but can have significant side effects including elevated blood pressure and glucose, increased appetite and weight gain.
A total of 1,565 patients aged 8-19 with bipolar disorder taking SGAs were enrolled in the study. Everyone enrolled in the trial received a lifestyle intervention with recommendations for healthy eating and exercise. Half of the youth were randomized to receive the healthy lifestyle intervention and were prescribed metformin, a medication typically used for Type 2 diabetes known to also prevent weight gain.
UC’s Jeffrey Welge, PhD, said in the short-term six-month follow-up data, metformin had a modest but significant effect at preventing and in some cases reversing weight gain in the study’s patient population. The drug was also found to be safe, with some gastrointestinal distress symptoms being the only side effects reported.
“It’s not a drug you take and weight falls off of you, but it tends to reduce that out of control appetite which we think then makes it easier for patients to adhere to a healthy diet and as they lose some weight maybe also make it easier for them to engage in more exercise,” said Welge, professor in UC’s Department of Psychiatry and Behavioral Neuroscience and Department of Environmental and Public Health Sciences. “So, the lifestyle is really what’s driving good outcomes, but metformin is in some cases putting the wind at their back to help with that.”
Read the U.S. News & World Report article.
Featured illustration at top of children in silhouette walking with colorful backpacks. Photo/A-Digit/iStock.
Related Stories
U.S. News & World Report: Metformin may help young patients with bipolar disorder avoid weight gain
October 31, 2023
U.S. News & World Report highlighted recent research led by the University of Cincinnati and Northwell Health that found the drug metformin can help prevent or reduce weight gain in youth taking medication to treat bipolar disorder.
Cape Girardeau, Missouri news highlights UC clinical trial
February 20, 2024
KFVS-TV in Cape Girardeau, Missouri highlighted a University of Cincinnati clinical trial testing a wearable neurostimulation device to help patients with opioid use disorder and post-traumatic stress disorder stick with medication treatment while finding the right dose.
Study: Strawberry consumption may reduce dementia risk for middle-aged individuals
November 2, 2023
New research from the University of Cincinnati found that daily strawberry consumption could help reduce the risk of dementia for certain middle-aged populations.
Enquirer: Experts discuss reasons for drop in overdose deaths
April 12, 2023
The University of Cincinnati's Christine Wilder, MD, spoke with the Cincinnati Enquirer about Hamilton County data that overdose deaths in 2022 dropped for the first time in six years.
WCPO: UC expert, former police sergeant touring country to help stop veteran suicides
October 25, 2023
The University of Cincinnati's Kate Chard and former Cincinnati Police Department sergeant Dave Corlett spoke with WCPO about their work to prevent veteran suicides through training tied to workplace stress and PTSD in law enforcement and the veteran community.
Is ketamine the answer to treatment-resistant depression?
May 16, 2024
![WVXU logo](/content/dam/refresh/uc-news/news-icons/dark/wvxu.png)
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.
Putting control in patients' hands
February 6, 2024
A new University of Cincinnati trial, in partnership with Spark Biomedical, will test a wearable neurostimulation device to help patients with opioid use disorder and post-traumatic stress disorder stick with medication treatment while finding the right dose.
Improving youth mental and physical health
October 27, 2023
A new large-scale study led by researchers at the University of Cincinnati and Northwell Health found the drug metformin can help prevent or reduce weight gain in youth taking medication to treat bipolar disorder.
Neuroimaging, AI help detect brain changes
May 1, 2024
Researchers at the University of Cincinnati and Dell Medical School at the University of Texas at Austin are leading a study using state-of-the-art neuroimaging techniques and artificial intelligence to identify changes in the brains among children of adults living with bipolar disorder.
Cincinnati Edition: A new way to treat depression
February 17, 2021
A researcher at the University of Cincinnati is studying whether electrical stimulation of the spinal cord can be helpful in treating certain psychiatric conditions, like depression.